KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Mycobacterium tuberculosis (isoniazid-resistant + rifampicin-resistant)

• Mycobacterium tuberculosis
• Mycobacterium tuberculosis (14d)
• Mycobacterium tuberculosis (180)
• Mycobacterium tuberculosis (190)
• Mycobacterium tuberculosis (210)
• Mycobacterium tuberculosis (2219 + rifampin-susceptible)
• Mycobacterium tuberculosis (2227 + rifampin-susceptible)
• Mycobacterium tuberculosis (2230 + rifampin-susceptible)
• Mycobacterium tuberculosis (2275 + rifampin-susceptible)
• Mycobacterium tuberculosis (2624 + rifampin-susceptible)
• Mycobacterium tuberculosis (27 + rifampin-susceptible)
• Mycobacterium tuberculosis (2749 + rifampin-susceptible)
• Mycobacterium tuberculosis (2831 + rifampin-susceptible)
• Mycobacterium tuberculosis (2847 + rifampin-susceptible)
• Mycobacterium tuberculosis (29 + rifampin-susceptible)
• Mycobacterium tuberculosis (2932 + rifampin-susceptible)
• Mycobacterium tuberculosis (2983 + rifampin-susceptible)
• Mycobacterium tuberculosis (3064 + rifampin-susceptible)
• Mycobacterium tuberculosis (31 + rifampin-susceptible)
• Mycobacterium tuberculosis (3113 + rifampin-susceptible)
• Mycobacterium tuberculosis (3125 + rifampin-susceptible)
• Mycobacterium tuberculosis (3147 + rifampin-susceptible)
• Mycobacterium tuberculosis (33 + rifampin-susceptible)
• Mycobacterium tuberculosis (331)
• Mycobacterium tuberculosis (35 + rifampin-susceptible)
• Mycobacterium tuberculosis (7d)
• Mycobacterium tuberculosis (9 + rifampin-susceptible)
• Mycobacterium tuberculosis (ATCC 25177 + H37Ra)
• Mycobacterium tuberculosis (ATCC 25177)
• Mycobacterium tuberculosis (ATCC 25178)
• Mycobacterium tuberculosis (ATCC 25179)
• Mycobacterium tuberculosis (ATCC 25180)
• Mycobacterium tuberculosis (ATCC 27294 + H37Rv)
• Mycobacterium tuberculosis (ATCC 27294 + isoniazid-resistant)
• Mycobacterium tuberculosis (ATCC 27294 + isoniazid-susceptible + rifampin-susceptible)
• Mycobacterium tuberculosis (ATCC 27294 + rifampicin-resistant)
• Mycobacterium tuberculosis (ATCC 27294 + streptomycin-resistant)
• Mycobacterium tuberculosis (ATCC 27294)
• Mycobacterium tuberculosis (ATCC 35801 + Erdman)
• Mycobacterium tuberculosis (ATCC 35801)
• Mycobacterium tuberculosis (BACTEC 460 + H37Ra)
• Mycobacterium tuberculosis (BACTEC 460 + H37Ragfp)
• Mycobacterium tuberculosis (Beijing + F29 + multidrug-resistant)
• Mycobacterium tuberculosis (Beijing + multidrug-resistant)
• Mycobacterium tuberculosis (Beijing)
• Mycobacterium tuberculosis (CCKO 28469V)
• Mycobacterium tuberculosis (clinical 900216 + pH 6.8)
• Mycobacterium tuberculosis (clinical isolate 900145 + pH 6.8)
• Mycobacterium tuberculosis (clinical isolate 900145 + pH 7.4)
• Mycobacterium tuberculosis (clinical isolate 900216 + pH 6.8)
• Mycobacterium tuberculosis (clinical isolate 900216 + pH 7.4)
• Mycobacterium tuberculosis (clinical isolate + multidrug-resistant)
• Mycobacterium tuberculosis (clinical isolate + pH 6.0)
• Mycobacterium tuberculosis (clinical isolate + pH 6.8)
• Mycobacterium tuberculosis (clinical isolate)
• Mycobacterium tuberculosis (clinical isolate-susceptible)
• Mycobacterium tuberculosis (ethambutol-resistant)
• Mycobacterium tuberculosis (first-line-antituberculosis-drugs-resistant)
• Mycobacterium tuberculosis (first-line-antituberculosis-drugs-susceptible)
• Mycobacterium tuberculosis (fluoroquinolone-resistant)
• Mycobacterium tuberculosis (GFPMA H37Ragfp)
• Mycobacterium tuberculosis (glycopeptide-resistant (A) + 94N)
• Mycobacterium tuberculosis (glycopeptide-resistant (A) + A90V)
• Mycobacterium tuberculosis (glycopeptide-resistant (A) + D94G)
• Mycobacterium tuberculosis (glycopeptide-resistant (A) + S91P)
• Mycobacterium tuberculosis (glycopeptide-resistant (B) + D500N)
• Mycobacterium tuberculosis (GN/mt-75)
• Mycobacterium tuberculosis (H37R + pH 6.8)
• Mycobacterium tuberculosis (H37R + pH 7.4)
• Mycobacterium tuberculosis (H37Ra)
• Mycobacterium tuberculosis (H37Rv + ethambutol-resistant)
• Mycobacterium tuberculosis (H37Rv + isoniazid-resistant)
• Mycobacterium tuberculosis (H37Rv + pH6.0)
• Mycobacterium tuberculosis (H37Rv + pH6.8)
• Mycobacterium tuberculosis (H37Rv + rifampicin-resistant)
• Mycobacterium tuberculosis (H37Rv + streptomycin-resistant)
• Mycobacterium tuberculosis (H37Rv)
• Mycobacterium tuberculosis (isoniazid-resistant + ifampicin-resistant)
• Mycobacterium tuberculosis (isoniazid-resistant + rifampicin-resistant)
• Mycobacterium tuberculosis (isoniazid-resistant + rifampin-resistant)
• Mycobacterium tuberculosis (isoniazid-resistant + streptomycin-resistant)
• Mycobacterium tuberculosis (isoniazid-resistant)
• Mycobacterium tuberculosis (levofloxacin-resistant)
• Mycobacterium tuberculosis (levofloxacin-susceptible)
• Mycobacterium tuberculosis (multidrug drug resistant)
• Mycobacterium tuberculosis (multidrug-resistant)
• Mycobacterium tuberculosis (non-multidrug-resistant)
• Mycobacterium tuberculosis (pH 5.5)
• Mycobacterium tuberculosis (pH 6.8)
• Mycobacterium tuberculosis (pyrazinamide-resistant)
• Mycobacterium tuberculosis (quinolone-resistant)
• Mycobacterium tuberculosis (rifampicin-resistant)
• Mycobacterium tuberculosis (rifampicin-susceptible)
• Mycobacterium tuberculosis (rifampin-resistant)
• Mycobacterium tuberculosis (rifampin-susceptible)
• Mycobacterium tuberculosis (streptomycin-resistant)
• Mycobacterium tuberculosis (TMCC 102 + ATCC 27294)
• Mycobacterium tuberculosis (TMCC 107 + Erdman)
• Mycobacterium tuberculosis (TMCC 25711 + H37Ra)
• Mycobacterium tuberculosis (UMF 15:099)
• Mycobacterium tuberculosis (W-Beijing + multidrug-resistant)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8